Trastuzumab improved overall survival in early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
A DNA vaccine targeting the breast cancer-associated antigen mammaglobin-A was proven safe and found to effectively elicit immune responses in women with metastatic breast cancer, according to a new study.
Breast cancer patients with BRCA 1/2 gene mutations do not have an increased risk of anthracycline-induced cardiac toxicity.
There is no associated between migraines and risk of breast cancer.
Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
An increasing number of of women eligible for breast conservation surgery (BCS) are opting instead for mastectomy, breast reconstruction, and bilateral mastectomy.
Two-thirds of breast-conserving surgical patients undergo six to seven weeks of radiation, but three weeks of higher-dose radiation could be more beneficial.
Deleterious mutations were identified in 14.6 percent of patients in a cohort unselected for family history.
The surveillance and follow-up of breast cancer survivors has the potential to improve, from the perspective of both patients and the health system.
A recent study recommends that patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2.
Many breast cancer cases in mothers can be averted if women do not smoke cigarettes prior to the birth of their first child.
An experimental breast cancer vaccine boosts immune response and appears to slow spread in those with advanced disease.
Telephone counseling after genetic testing was found just as effective as in-person counseling in many respects, according to new study.
Bisposphonates may also prevent certain types of breast, colon, and lung cancers.
Combining genetic data with information on other risk factors could significantly improve the ability to identify women at highest risk of developing breast cancer, according to a new study.
Significant improvements in breast cancer outcomes found despite similar patterns of relapse, research shows.
Nearly one quarter of all women who underwent initial breast conservation surgery (BCS) for breast cancer had a subsequent surgical intervention.
Exercise offers several benefits for breast cancer survivors, including reduced symptoms of lymphedema, according to a new study.
Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.
Participants in prosocial versus standard group have higher level of depression, anxiety after intervention.
Better breast reconstruction outcomes may be one reason behind the trend of increasing mastectomy rates for early-stage breast cancer patients eligible for lumpectomy.
Distressed survivors or breast cancer may not benefit from helping others, as the helper therapy principle would suggest.
More than 70% of women who have had breast cancer experience menopausal problems, hot flushes in particular, and some cancer survivors consider giving up their post cancer medication to mitigate these conditions.
Complementary, alternative medicine may have higher risk for excessive bleeding during breast cancer surgery
Breast cancer patients using herbal supplements had increased risk for adverse bleeding-related outcomes.
More women with breast cancer are opting for mastectomy rather than undergoing breast conservation surgery.
Women who take calcium channel blockers to treat their hypertension are not at increased risk for developing breast cancer.
Partial breast irradiation (APBI) with proton therapy, as opposed to whole breast irradiation (WBI), may prove more affordable and have a more beneficial length of treatment for patients with early stage breast cancer.
SERMs and aromatase inhibitors have been proven to be excellent agents in the preventive setting for ER-positive breast cancer, but newer agents must be found specifically for ER-negative breast cancers, which mostly occur in premenopausal women.
Reduction in distress, unmet information needs with telephone-based, peer-support program
Researchers have demonstrated that employing mindfulness meditation or being a member of a support group has a positive physical impact at the cellular level in breast cancer survivors.
Newly developed software enables genetic mutation analysis of breast cancer tumors, allowing for greater accuracy.
The addition of tomosynthesis to biennial digital mammography screening for women with dense breasts should improve breast cancer detection at a reasonable cost.
What are the treatment options for recurrent metastatic HER2-positive breast cancer after trastuzumab therapy?
The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer
A majority of breast cancer patients in the U.S. use complementary therapies after a breast cancer diagnosis, but there has been little science-based guidance about their safety and effectiveness.
Patients of Mexican descent with breast cancer and family history of breast or ovarian cancer were nearly two times as likely to have triple negative breast cancer.
Diffuse optical spectroscopic tomographic imaging (DOST) may be useful in predicting which patients will best respond to chemotherapy used to reduce breast cancer tumors before surgery, according to a new study.
Latina patients with breast cancer had much more awareness of clinical trials versus women who received the typical information.
People who are lactose intolerant have a decreased risk for developing breast, lung, and ovarian cancers.
The addition of trastuzumab to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.
Tai chi may reduce the risk of breast cancer recurrence by decreasing inflammation in patients who have had breast cancer.
Women with breast cancer are at an increased long-term risk for developing first depression.
Location of a breast cancer tumor, on the left or right side, does not impact overall survival in patients treated with breast-conserving surgery and adjuvant external beam radiation therapy.
Cancer stage may play a role in the decision to undergo mastectomy rather than lumpectomy for women with early stage breast cancer, according to recent research.
Researchers identified the benefits of exercise therapy and electro-acupuncture in breast cancer survivors.
For black women and Hispanic women, obesity increases postmenopausal risk of estrogen receptor (ER)-negative and progesterone receptor-positive breast cancer.
Mindfulness mediation has effects on the cellular level of the body of breast cancer survivors.
As cancer care evolves toward anticipatory rather than reactionary care, oncology nurses should consider developing important new skills.
Hot flashes experienced by women who have been treated for breast cancer are not being sufficiently addressed by clinicians.
A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.
Cost is a key factor for women to maintain their hormone treatment regimen, researchers report.
The combined breast screening cost-effective over a range of incremental improvements in test performance.
The researchers found that the sensitivity, false-positive rate, and cancer detection rate of screening mammography increased with increasing numbers of radiologist work-ups for their own recalled mammograms.
Invisible tattoos preferable option to mark where a patient with breast cancer should receive radiotherapy during sessions.
What vaginal lubricants are available for for women with hormone-receptor positive (HR+) cancer?
For patients with schizophrenia and breast cancer, initial radical surgery without adjuvant radiation therapy may be preferred.
Pre-existing diabetes increases risk of total mortality among women with breast cancer.
A recent study has found a modest association between smoking and breast cancer risk in women.
When breast and colorectal cancers occur in children, the diseases are aggressive.
Generic aromatase inhibitors improved treatment adherence by 50% in hormone receptor-positive breast cancer.
Relaxation and yoga are the best complementary therapies for the treatment of breast cancer.
Recent trial investigated the impact of a yoga intervention on fatigue and inflammation among breast cancer survivors.
Children who underwent chest radiation for the treatment of Wilms tumor may have an increased risk for developing breast cancer.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.
A change in diagnosis resulted from PET/CT imaging of patients who were younger than 40 years with an initial diagnosis of stage I-III breast cancer, according to a retrospective analysis.
'Extra Help' program allows more women of varying racial and ethnic backgrounds to continue their hormone therapy.
Patients with HER2-positive breast cancer that has metastasized demonstrate longer survival outcomes if treated with a combination of pertuzumab, trastuzumab, and chemotherapy.
A healthy lifestyle may improve survival of patients with breast cancer.
Women treated for breast cancer improved their quality of life after participating in post-treatment intervention.
Human epidermal growth factor receptor 2 (HER2) mutations may offer an important treatment target in a subset of patients with non-small cell lung cancer.
Breast cancer experts world-wide have urged for continued high quality research on advanced breast cancer.
Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) study confirms use of trastuzumab for HER2-positive breast cancer
The use of trastuzumab (Herceptin) as the standard-of-care treatment for HER2-positive breast cancer has been supported by the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) study.
Researchers have successfully tested a new tool that will help surgeons better distinguish cancerous breast tissue from normal tissue, which should lower the mount of repeat procedures needed.
Referrals for genetic counseling and testing for breast cancer risk more than doubled across the United Kingdom after Angelina Jolie's May 2013 announcement she tested positive for BRCA1 gene mutation and underwent a double mastectomy.
For patients with breast cancer, oral bisphosphonates may reduce risk for developing bone metastases
Oral bisphosphonates to treat osteoporosis may also slow skeletal metastases caused by breast cancer.
[Breast Cancer (Auckl)] Breast positioning is the key factor affecting a mammogram. Done properly, correct positioning maximizes the amount of breast tissue being imaged, eliminates most of the artifacts, and increases sensitivity of the mammogram.
Scientists are now developing an "electronic skin" that will aid in the detection of breast masses.
Exposure to dim light at night may make breast tumors resistant to chemotherapy
Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.
Adding carboplatin and/or bevacizumab to the standard treatment regimen significantly improved pathologic complete response rates in patients with triple-negative breast cancer, according to a new phase 2 study.
Drug should remain standard of care for HER2-positive tumors, according to new research.
A recent study found no link between bra wearing and increased breast cancer risk among postmenopausal women.
An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.
Is there a good reason to mix nab-paclitaxel (Abraxane) with warm (not cool) normal saline when reconstituting?
A new immunotherapy vaccine candidate for breast cancer shows promise, having reduced recurrence rate by more than fifty percent.
Women whose skirt size increases one size every 10 years have a 33% increased risk for developing breast cancer.
The experimental drug nintedanib, in combination with standard paclitaxel chemotherapy, caused a total remission of tumors in half of patients with early stage HER2-negative breast cancer.
Most women who chose to undergo double mastectomies despite having cancer in only one breast are content with their choice.
Mammograms for those aged 69 to 75 could result in over-treatment, researchers caution.
Scientists have developed a tool to distinguish each breast cancer subtype, research that could improve treatments and targeting of treatments for the disease.
Breast cancer cells can lay the groundwork for their own metastasis throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals.
The BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared with the use of conventional IHC-FISH pathology tests, according to a new study.
One-third of women who are given information about the potential for over-diagnosis through the National Health Services (NHS) breast screening program may not completely understand the risks involved.
Screening women for breast cancer up to age 75 may lead to overdiagnosis and overtreatment.
Postmenopausal women with a diverse gut microbiome have higher levels of estrogen metabolites.
The percentage of women that underwent a double mastectomy increased substantially between 1998 and 2011, even though the procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation.
Women with severe disabilities and multiple chronic conditions are screened for breast cancer less often than women with no disabilities or no chronic conditions.
GP2, a novel immunotherapy, has demonstrated a reduction in recurrence in patients with breast cancer.
Integrated approach to pinpoint genetic drivers of cancer uncovers viable targets for breast cancer therapy
Researchers have developed a new integrated approach to identify the genetic drivers of cancer, uncovering eight genes necessary for cell proliferation in breast cancer.
Study raises questions about the effect of soy's estrogen-like properties.
- Added sugars may increase blood pressure more than high salt consumption
- Researchers identify biological indicator of response to new ovarian cancer drug
- Key discovery in understanding successes and failures of immunotherapy
- Managing obesity should be part of cancer care
- Galeterone active in one form of castration-resistant prostate cancer
- Rociletinib produces response in treatment-resistant advanced non-small cell lung cancer (NSCLC)
- Utilizing home therapy for cancer-related lymphedema can lower costs
- Drug combination produces good response rates in advanced papillary renal cell carcinoma (pRCC)
- Breast cancer and pregnancy: Overlapping of two disciplines
- IDH1 mutation inhibitor first to demonstrate anticancer activity
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|